Table 3 Adverse events observed or reported during the study follow-up.
Adverse events, n (%) | Overall | PMS | PMS + Phaco | p |
|---|---|---|---|---|
Hypotony* | 1 (1.7) | 1 (2.8) | 0 (0.0) | 0.4223 |
Seidel | 3 (5.2) | 1 (2.8) | 2 (8.7) | 0.3237 |
Device obstruction | 2 (3.5) | 2 (5.7) | 0 (0.0) | 0.2480 |
Choroidal detachment | 2 (3.5) | 1 (2.8) | 1 (4.3) | 0.7597 |
Conjunctival fibrosis | 5 (8.6) | 3 (8.6) | 2 (8.7) | 0.9895 |
Hyphema | 2 (3.5) | 1 (2.8) | 1 (4.3) | 0.7597 |
Device close-to-endothelium | 5 (8.6) | 3 (8.6) | 2 (8.7) | 0.9895 |
Implant extrusion | 1 (1.7) | 1 (2.8) | 0 (0.0) | 0.4223 |
